Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing Enterobacterales

被引：9
作者：
Shapiro, Stuart [1 ]
机构：
[1] Harry Lime Inst Penicillin Res, Basel, Switzerland
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2022年 / 66卷 / 05期
关键词：
beta-lactamase inhibitors; ESBL; cefepime; enmetazobactam;
D O I：
10.1128/aac.00298-22
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales
    Carlos Vazquez-Ucha, Juan
    Lasarte-Monterrubio, Cristina
    Guijarro-Sanchez, Paula
    Oviano, Marina
    Alvarez-Fraga, Laura
    Alonso-Garcia, Isaac
    Arca-Suarez, Jorge
    Bou, German
    Beceiro, Alejandro
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [2] Clinical and Laboratory Standards Institute, 2022, PERFORMANCE STANDARD, V32nd ed
  • [3] Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019
    Karlowsky, James A.
    Lob, Sibylle H.
    DeRyke, C. Andrew
    Siddiqui, Fakhar
    Young, Katherine
    Motyl, Mary R.
    Sahm, Daniel F.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (03)
  • [4] Kaye KS., 2021, OPEN FORUM INFECT DI, V8, pS421, DOI [10.1093/ofid/ofab466.834, DOI 10.1093/OFID/OFAB466.834]
  • [5] Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017
    Kazmierczak, Krystyna M.
    Karlowsky, James A.
    de Jonge, Boudewijn L. M.
    Stone, Gregory G.
    Sahm, Daniel F.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (07)
  • [6] Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
    Kazmierczak, Krystyna M.
    Rabine, Sharon
    Hackel, Meredith
    McLaughlin, Robert E.
    Biedenbach, Douglas J.
    Bouchillon, Samuel K.
    Sahm, Daniel F.
    Bradford, Patricia A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) : 1067 - 1078
  • [7] Sigmoid Emax Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime
    Knechtle, Philipp
    Shapiro, Stuart
    Morrissey, Ian
    De Piano, Cyntia
    Belley, Adam
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
  • [8] Morrissey I, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00514-19, 10.1128/aac.00514-19]
  • [9] Papp-Wallace KM, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00105-19, 10.1128/aac.00105-19]
1